Literature DB >> 33374629

Health-Related Quality of Life and Related Factors in Persons with Preserved Ratio Impaired Spirometry: Data from the Korea National Health and Nutrition Examination Surve.

I Re Heo1, Ho Cheol Kim1, Tae Hoon Kim1.   

Abstract

Background and
Objectives: preserved ratio impaired spirometry (PRISm) is a common spirometric pattern that causes respiratory symptoms, systemic inflammation, and mortality. However, its impact on health-related quality of life (HRQOL) and its associated factors remain unclear. We aimed to identify these HRQOL-related factors and investigate the differences in HROOL between persons with PRISm and those with normal lung function. Materials and
Methods: we reviewed the Korea National Health and Nutrition Examination Survey data from 2008 to 2013 to evaluate the HRQOL of persons with PRISm, as measured while using the Euro Quality of Life-5D (EQ-5D) and identify any influencing factors. PRISm was defined as pre-bronchodilator forced expiratory volume in 1 s (FEV1) <80% predicted and FEV1 to forced vital capacity (FVC) ratio (FEV1/FVC) ≥0.7. Individuals with FEV1 ≥80% predicted and FEV1/FVC ≥0.7 were considered as Controls.
Results: of the 27,824 participants over the age of 40 years, 1875 had PRISm. The age- and sex-adjusted EQ-5D index was lower in the PRISm group than in the control group (PRISm, 0.930; control, 0.941; p = 0.005). The participants with PRISm showed a significantly higher prevalence of hypertension (p < 0.001), diabetes (p < 0.001), obesity (p < 0.001), low physical activity (p = 0.001), ever-smoker (p < 0.001), and low income (p = 0.034) than those in the control group. In participants with PRISm, lower EQ-5D index scores were independently associated with old age (p = 0.002), low income (p < 0.001), low education level (p < 0.001), and no economic activity (p < 0.001). Three out of five EQ-5D dimensions (mobility, self-care, and usual activity) indicated a higher proportion of dissatisfied participants in the PRISm group than the control group. Conclusions: the participants with PRISm were identified to have poor HRQOL when compared to those without PRISm. Old age and low socioeconomic status play important roles in HRQOL deterioration in patients with PRISm. By analyzing risk factors that are associated with poor HRQOL, early detection and intervention of PRISm can be done in order to preserve patients' quality of life.

Entities:  

Keywords:  Euro Quality of Life-5D; chronic obstructive pulmonary disease; preserved ratio impaired spirometry; quality of life; restrictive lung disease

Mesh:

Year:  2020        PMID: 33374629      PMCID: PMC7822493          DOI: 10.3390/medicina57010004

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  37 in total

1.  Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study.

Authors:  Emily S Wan; John E Hokanson; James R Murphy; Elizabeth A Regan; Barry J Make; David A Lynch; James D Crapo; Edwin K Silverman
Journal:  Am J Respir Crit Care Med       Date:  2011-04-14       Impact factor: 21.405

2.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire.

Authors:  P W Jones; F H Quirk; C M Baveystock; P Littlejohns
Journal:  Am Rev Respir Dis       Date:  1992-06

3.  Abdominal adiposity is an early marker of pulmonary function impairment: Findings from a Mediterranean Italian female cohort.

Authors:  A Vatrella; C Calabrese; A Mattiello; C Panico; A Costigliola; P Chiodini; S Panico
Journal:  Nutr Metab Cardiovasc Dis       Date:  2016-01-02       Impact factor: 4.222

4.  COPD: A New Diagnostic Paradigm.

Authors:  Barry J Make
Journal:  Chronic Obstr Pulm Dis       Date:  2019-11

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

Authors:  Jørgen Vestbo; Suzanne S Hurd; Alvar G Agustí; Paul W Jones; Claus Vogelmeier; Antonio Anzueto; Peter J Barnes; Leonardo M Fabbri; Fernando J Martinez; Masaharu Nishimura; Robert A Stockley; Don D Sin; Roberto Rodriguez-Roisin
Journal:  Am J Respir Crit Care Med       Date:  2012-08-09       Impact factor: 21.405

6.  [The decline of health-related quality of life associated with some diseases in Korean adults].

Authors:  Seol Ryoung Kil; Sang-Il Lee; Sung-Cheol Yun; Hyung-Mi An; Min-Woo Jo
Journal:  J Prev Med Public Health       Date:  2008-11

7.  Lung function and risk of type 2 diabetes and fatal and nonfatal major coronary heart disease events: possible associations with inflammation.

Authors:  S Goya Wannamethee; A Gerald Shaper; Ann Rumley; Naveed Sattar; Peter H Whincup; Mary C Thomas; Gordon D Lowe
Journal:  Diabetes Care       Date:  2010-06-02       Impact factor: 19.112

8.  Longitudinal Phenotypes and Mortality in Preserved Ratio Impaired Spirometry in the COPDGene Study.

Authors:  Emily S Wan; Spyridon Fortis; Elizabeth A Regan; John Hokanson; MeiLan K Han; Richard Casaburi; Barry J Make; James D Crapo; Dawn L DeMeo; Edwin K Silverman
Journal:  Am J Respir Crit Care Med       Date:  2018-12-01       Impact factor: 30.528

9.  Restrictive Spirometry Pattern, Cardiac Structure and Function, and Incident Heart Failure in African Americans. The Jackson Heart Study.

Authors:  Matthew Jankowich; Beth Elston; Qing Liu; Siddique Abbasi; Wen-Chih Wu; Chad Blackshear; Mark Godfrey; Gaurav Choudhary
Journal:  Ann Am Thorac Soc       Date:  2018-10

10.  Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES).

Authors:  Sanghui Kweon; Yuna Kim; Myoung-jin Jang; Yoonjung Kim; Kirang Kim; Sunhye Choi; Chaemin Chun; Young-Ho Khang; Kyungwon Oh
Journal:  Int J Epidemiol       Date:  2014-02       Impact factor: 7.196

View more
  1 in total

1.  Impact of coexistent preserved ratio impaired spirometry on the survival of patients with lung cancer: Analysis of data from the Korean Association for Lung Cancer Registry.

Authors:  I Re Heo; Ho Cheol Kim; Seung Jun Lee; Jung-Wan Yoo; Sunmi Ju; Yi Yeong Jeong; Jong Deog Lee; Yu Ji Cho; Jong Hwan Jeong; Manbong Heo; Seung Woo Jung; Tae Hoon Kim
Journal:  Thorac Cancer       Date:  2021-08-01       Impact factor: 3.500

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.